Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Finding drug information can be hard – healthcare providers need digital solutions
Posted on October 5th, 2021 by Ann-Marie Roche in Medical Information
The digital transformation in our world was already happening quite rapidly in recent years, but then the COVID-19 pandemic accelerated many aspects of it. Not only did schools and businesses have to learn to function online, but everything from doctor’s visits to dance parties were frequently being conducted on the internet. But even as many sectors have made the digital transition, some areas have continued to lag behind.
(more…)AI precision medicine accelerates the search for rare disease treatment
Posted on September 20th, 2021 by Ann-Marie Roche in AI & Data
AI and precision medicine are both changing drug discovery and development as we know it. Precision medicine that is powered by AI stands to be transformative, especially for the treatment of rare diseases. Elsevier was recently part of a collaboration that sought to demonstrate how AI precision medicine could lead researchers to new treatments for brain tumors faster.
(more…)Confronting the Problem of AI Bias
Posted on June 18th, 2021 by Ann-Marie Roche in AI & Data
When thinking of artificial intelligence (AI), many people rely on cultural touchstones from science fiction films and TV. They might think of HAL, the calm-voiced AI from 2001: A Space Odyssey, or Data, the even-tempered android from Star Trek. We tend to imagine that artificial intelligence will be driven by reason, logic and facts – not by the emotions and prejudices that get us regular humans into trouble so often.
(more…)4 Notable Life Sciences Trends from the Tech Trends Report
Posted on June 4th, 2021 by Ann-Marie Roche in AI & Data
The Future Today Institute has released its 2021 Tech Trends Report (14th Annual Edition), a comprehensive report on strategic trends that it anticipates will affect business, government, education, media and society in the coming year. We noted four trends discussed in the report’s Health, Medicine & Science section that will be of particular interest to those in the pharmaceutical and life sciences sectors.
(more…)
